NCT02459067View on ClinicalTrials.gov

ImmuniCell® in Patients With Advanced Cancers

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 27, 2018

Study Completion Date

November 27, 2018

Conditions
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
Interventions
BIOLOGICAL

ImmuniCell®

Autologous γδ T Lymphocytes

Trial Locations (7)

Unknown

Velindre Cancer Centre and University Hospital of Wales, Cardiff

Western General Hospital, Edinburgh

Beatson West of Scotland Cancer Centre, Glasgow

St. James's University Hospital, Leeds

University College London Hospital, London

Churchill Hospital, Oxford

Southampton General Hospital, Southampton

Sponsors

Lead Sponsor

TC Biopharm
All Listed Sponsors
lead

TC Biopharm

INDUSTRY

NCT02459067 - ImmuniCell® in Patients With Advanced Cancers | Biotech Hunter | Biotech Hunter